Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (371-380 of 676) with videos related to

Pageof 68
Sort By:
The Annals of Pharmacotherapy|August 19, 2003
Intravenous corticosteroids to reduce gemtuzumab ozogamicin infusion reactionsFrancis J Giles, Jorge E Cortes, Terri A Halliburton, et al.
Critical Care (London, England)|June 10, 2003
Case report: severe mercuric sulphate poisoning treated with 2,3-dimercaptopropane-1-sulphonate and haemodiafiltrationPaul I Dargan, Lucy J Giles, Craig I Wallace, et al.
Pharmacology & Therapeutics|September 7, 2016
The functional interplay between systemic cancer and the hematopoietic stem cell nicheAmber J Giles, Christopher D Chien, Caitlin M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab dose-escalation trial in chronic lymphocytic leukemiaS M O'Brien, H Kantarjian, D A Thomas, et al.
Schizophrenia Bulletin|September 28, 2021
Obstructive Sleep Apnea Is Treatable With Continuous Positive Airway Pressure in People With Schizophrenia and Other Psychotic DisordersJamilla J Giles, Ivan Ling, Nigel McArdle, et al.
British Journal of Haematology|May 18, 2006
Plasma as a source of mRNA for determining IgV(H) mutation status in patients with chronic lymphocytic leukaemiaW Ma, I Jilani, M Gorre, et al.
British Journal of Haematology|June 22, 2011
Targeting PIM kinase activity significantly augments the efficacy of cytarabineKevin R Kelly, Claudia M Espitia, Pietro Taverna, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid LeukemiaGeorg-Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, et al.
International Journal of Molecular Medicine|January 3, 2020
Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancerTsutomu Anraku, Hiroo Kuroki, Akira Kazama, et al.
Science Translational Medicine|May 23, 2014
Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacySteven L Highfill, Yongzhi Cui, Amber J Giles, et al.
Pageof 68

Showing results (371-380 of 676) with videos related to

Sort By:
Pageof 68
The Annals of Pharmacotherapy|August 19, 2003
Intravenous corticosteroids to reduce gemtuzumab ozogamicin infusion reactionsFrancis J Giles, Jorge E Cortes, Terri A Halliburton, et al.
Critical Care (London, England)|June 10, 2003
Case report: severe mercuric sulphate poisoning treated with 2,3-dimercaptopropane-1-sulphonate and haemodiafiltrationPaul I Dargan, Lucy J Giles, Craig I Wallace, et al.
Pharmacology & Therapeutics|September 7, 2016
The functional interplay between systemic cancer and the hematopoietic stem cell nicheAmber J Giles, Christopher D Chien, Caitlin M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab dose-escalation trial in chronic lymphocytic leukemiaS M O'Brien, H Kantarjian, D A Thomas, et al.
Schizophrenia Bulletin|September 28, 2021
Obstructive Sleep Apnea Is Treatable With Continuous Positive Airway Pressure in People With Schizophrenia and Other Psychotic DisordersJamilla J Giles, Ivan Ling, Nigel McArdle, et al.
British Journal of Haematology|May 18, 2006
Plasma as a source of mRNA for determining IgV(H) mutation status in patients with chronic lymphocytic leukaemiaW Ma, I Jilani, M Gorre, et al.
British Journal of Haematology|June 22, 2011
Targeting PIM kinase activity significantly augments the efficacy of cytarabineKevin R Kelly, Claudia M Espitia, Pietro Taverna, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid LeukemiaGeorg-Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, et al.
International Journal of Molecular Medicine|January 3, 2020
Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancerTsutomu Anraku, Hiroo Kuroki, Akira Kazama, et al.
Science Translational Medicine|May 23, 2014
Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacySteven L Highfill, Yongzhi Cui, Amber J Giles, et al.
Pageof 68